Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Newman AC, Maddocks ODK. One-carbon metabolism in cancer. Br J Cancer. 2017;116:1499–504.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ueland PM. Choline and betaine in health and disease. J Inherit Metab Dis. 2011;34:3–15.

Article  CAS  PubMed  Google Scholar 

Ueland PM, Holm PI, Hustad S. Betaine: a key modulator of one-carbon metabolism and homocysteine status. Clin Chem Lab Med. 2005;43:1069–75.

Article  CAS  PubMed  Google Scholar 

Arumugam MK, Paal MC, Donohue TM Jr, Ganesan M, Osna NA, Kharbanda KK. Beneficial Effects of Betaine: a Comprehensive Review. Biology (Basel) 2021, 10.

da Costa KA, Niculescu MD, Craciunescu CN, Fischer LM, Zeisel SH. Choline deficiency increases lymphocyte apoptosis and DNA damage in humans. Am J Clin Nutr. 2006;84:88–94.

Article  PubMed  Google Scholar 

Zeisel SH. Dietary choline deficiency causes DNA strand breaks and alters epigenetic marks on DNA and histones. Mutat Res. 2012;733:34–8.

Article  CAS  PubMed  Google Scholar 

Du YF, Lin FY, Long WQ, Luo WP, Yan B, Xu M, Mo XF, Zhang CX. Serum betaine but not choline is inversely associated with breast cancer risk: a case-control study in China. Eur J Nutr. 2017;56:1329–37.

Article  CAS  PubMed  Google Scholar 

Myte R, Gylling B, Schneede J, Ueland PM, Häggström J, Hultdin J, Hallmans G, Johansson I, Palmqvist R, Van Guelpen B. Components of one-carbon Metabolism Other than Folate and Colorectal Cancer Risk. Epidemiology. 2016;27:787–96.

Article  PubMed  Google Scholar 

Huang JY, Luu HN, Butler LM, Midttun Ø, Ulvik A, Wang R, Jin A, Gao YT, Tan Y, Ueland PM, et al. A prospective evaluation of serum methionine-related metabolites in relation to pancreatic cancer risk in two prospective cohort studies. Int J Cancer. 2020;147:1917–27.

Article  CAS  PubMed  Google Scholar 

Sun S, Li X, Ren A, Du M, Du H, Shu Y, Zhu L, Wang W. Choline and betaine consumption lowers cancer risk: a meta-analysis of epidemiologic studies. Sci Rep. 2016;6:35547.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Youn J, Cho E, Lee JE. Association of choline and betaine levels with cancer incidence and survival: a meta-analysis. Clin Nutr. 2019;38:100–9.

Article  CAS  PubMed  Google Scholar 

Ambrosini GL, Fritschi L, de Klerk NH, Mackerras D, Leavy J. Dietary patterns identified using factor analysis and prostate cancer risk: a case control study in western Australia. Ann Epidemiol. 2008;18:364–70.

Article  PubMed  Google Scholar 

Richman EL, Kenfield SA, Stampfer MJ, Giovannucci EL, Chan JM. Egg, red meat, and poultry intake and risk of lethal prostate cancer in the prostate-specific antigen-era: incidence and survival. Cancer Prev Res (Phila). 2011;4:2110–21.

Article  CAS  PubMed  Google Scholar 

Sinha R, Park Y, Graubard BI, Leitzmann MF, Hollenbeck A, Schatzkin A, Cross AJ. Meat and meat-related compounds and risk of prostate cancer in a large prospective cohort study in the United States. Am J Epidemiol. 2009;170:1165–77.

Article  PubMed  PubMed Central  Google Scholar 

Xu R, Wang Q, Li L. A genome-wide systems analysis reveals strong link between colorectal cancer and trimethylamine N-oxide (TMAO), a gut microbial metabolite of dietary meat and fat. BMC Genomics. 2015;16(Suppl 7):4.

Article  Google Scholar 

Mondul AM, Moore SC, Weinstein SJ, Karoly ED, Sampson JN, Albanes D. Metabolomic analysis of prostate cancer risk in a prospective cohort: the alpha-tocolpherol, beta-carotene cancer prevention (ATBC) study. Int J Cancer. 2015;137:2124–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reichard CA, Naelitz BD, Wang Z, Jia X, Li J, Stampfer MJ, Klein EA, Hazen SL, Sharifi N. Gut microbiome-dependent metabolic pathways and risk of Lethal prostate Cancer: prospective analysis of a PLCO Cancer Screening Trial Cohort. Cancer Epidemiol Biomarkers Prev. 2022;31:192–9.

Article  CAS  PubMed  Google Scholar 

Bae S, Ulrich CM, Neuhouser ML, Malysheva O, Bailey LB, Xiao L, Brown EC, Cushing-Haugen KL, Zheng Y, Cheng TY, et al. Plasma choline metabolites and colorectal cancer risk in the women’s Health Initiative Observational Study. Cancer Res. 2014;74:7442–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Vogel S, Ulvik A, Meyer K, Ueland PM, Nygård O, Vollset SE, Tell GS, Gregory JF 3rd, Tretli S, Bjørge T. Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer–a large nested case-control study within the JANUS cohort in Norway. Int J Cancer. 2014;134:197–206.

Article  PubMed  Google Scholar 

Guertin KA, Li XS, Graubard BI, Albanes D, Weinstein SJ, Goedert JJ, Wang Z, Hazen SL, Sinha R. Serum trimethylamine N-oxide, carnitine, Choline, and Betaine in Relation to Colorectal Cancer Risk in the alpha Tocopherol, Beta Carotene Cancer Prevention Study. Cancer Epidemiol Biomarkers Prev. 2017;26:945–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Butler LM, Arning E, Wang R, Bottiglieri T, Govindarajan S, Gao YT, Yuan JM. Prediagnostic levels of serum one-carbon metabolites and risk of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev. 2013;22:1884–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huo Y, Li J, Qin X, Huang Y, Wang X, Gottesman RF, Tang G, Wang B, Chen D, He M, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA. 2015;313:1325–35.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Li J, Liu C, Yu H, Chen C, Bi C, Fang C, Ma H, Li A, Dong Q, et al. High-density lipoprotein cholesterol and the risk of first ischemic stroke in a chinese Hypertensive Population. Clin Interv Aging. 2021;16:801–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu MS, Fang YJ, Pan ZZ, Zhong X, Zheng MC, Chen YM, Zhang CX. Choline and betaine intake and colorectal cancer risk in chinese population: a case-control study. PLoS ONE. 2015;10:e0118661.

Article  PubMed  PubMed Central  Google Scholar 

Zeng FF, Xu CH, Liu YT, Fan YY, Lin XL, Lu YK, Zhang CX, Chen YM. Choline and betaine intakes are associated with reduced risk of nasopharyngeal carcinoma in adults: a case-control study. Br J Cancer. 2014;110:808–16.

Article  CAS  PubMed  Google Scholar 

Xie L, Zhao BX, Luo J, Li Y, Zhu F, Li GF, He M, Wang B, Zhang H, Cai Y, et al. A U-shaped association between serum betaine and incident risk of first ischemic stroke in hypertensive patients. Clin Nutr. 2020;39:2517–24.

Article  CAS  PubMed  Google Scholar